Swathi NL | Nursing and Health Professions | Young Researcher Award

Young Researcher Award

Swathi NL
Researcher Swathi NL
Affiliation Manipal College of Nursing, Manipal Academy of Higher Education
Country India
Scopus ID 58336556300
Documents 25
Citations 26
h-index 3
Subject Area Nursing and Health Professions
Event International Young Scientists Award
ORCID 0000-0002-3695-0732

Swathi NL

Manipal College of Nursing, Manipal Academy of Higher Education, India

Swathi NL has established a developing research profile in the field of Nursing and Health Professions through peer-reviewed publications, interdisciplinary collaboration, and contributions to evidence-based healthcare research. Her scholarly record, indexed in Scopus, reflects consistent participation in academic research and knowledge dissemination.[1]

Abstract

Swathi NL is affiliated with Manipal College of Nursing, Manipal Academy of Higher Education, India. Her academic activities emphasize nursing science, patient-centered care, healthcare education, and evidence-based clinical practice. With twenty-five Scopus-indexed publications, twenty-six citations, and an h-index of three, her scholarly record reflects a growing contribution to nursing research and professional development. These achievements indicate active engagement in scientific communication, collaborative investigations, and healthcare improvement initiatives, supporting her recognition for the International Young Scientists Award.[1]

Keywords

Nursing Research, Evidence-Based Practice, Healthcare Education, Clinical Nursing, Public Health, Patient Care, Medical Research, Healthcare Innovation, Young Researcher Award, Nursing and Health Professions.

Introduction

The advancement of nursing science depends upon researchers who generate reliable evidence capable of improving healthcare quality, patient safety, and clinical decision-making. Young investigators contribute significantly by introducing innovative perspectives, conducting interdisciplinary studies, and promoting evidence-based healthcare solutions. Academic recognition programs encourage continued excellence by acknowledging researchers who demonstrate commitment to scientific inquiry, ethical standards, and professional collaboration.[2]

Research Profile

Swathi NL has developed a research portfolio centered on nursing and health professions through peer-reviewed publications and collaborative academic activities. Her Scopus metrics demonstrate continued scholarly productivity, while her ORCID profile supports transparent identification of research outputs. The combination of publications, citations, and measurable research impact reflects active participation within the international academic community.[1]

Research Contributions

  • Published research in Nursing and Health Professions.
  • Supported evidence-based healthcare practices.
  • Participated in interdisciplinary academic collaborations.
  • Contributed to scholarly communication through peer-reviewed publications.

Publications

According to the available Scopus author profile, Swathi NL has published twenty-five indexed documents that collectively contribute to the advancement of nursing knowledge and healthcare research. These publications demonstrate sustained scholarly engagement and provide measurable evidence of academic productivity within the field.[1]

Research Impact

Research impact is commonly evaluated using publication output, citation performance, collaboration, and scholarly influence. With twenty-six citations and an h-index of three, Swathi NL demonstrates an emerging research presence. Continued publication and collaboration are expected to strengthen the visibility and application of her research within nursing practice and healthcare education.[1]

Award Suitability

The academic profile of Swathi NL aligns with the objectives of the International Young Scientists Award by demonstrating early-career research productivity, professional engagement, and commitment to advancing nursing science. Her publication record, documented research metrics, and participation in scholarly activities provide objective indicators supporting consideration for recognition under the Young Researcher Award category.[3]

Conclusion

Swathi NL represents an emerging researcher whose academic activities contribute to Nursing and Health Professions through scientific publications, collaborative research, and evidence-based healthcare advancement. Her documented scholarly achievements and measurable research indicators support recognition within international academic award programs dedicated to encouraging promising researchers.

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Swathi NL, Author ID 58336556300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58336556300
  2. ORCID. (n.d.). ORCID Record: Swathi NL.
    https://orcid.org/0000-0002-3695-0732
  3. Young Scientist Awards. (n.d.). International Young Scientists Award.
    https://youngscientistawards.com/

Shivang Shukla | Pharmacy | Young Researcher Award

Mr. Shivang Shukla l Pharmacy
| Young Researcher Award

Jagannath University | India

The research focuses on advancing pharmacological science through multidisciplinary approaches involving drug discovery, nanotechnology, computational modeling, and translational pharmacology. Current investigations explore the computational identification of skeletal muscle-specific AMPK activators for type-2 diabetes therapy, aiming to enhance metabolic regulation and therapeutic efficacy. Additional studies examine the cardioprotective potential of Artocarpus heterophyllus against isoprenaline-induced myocardial infarction and the neuroprotective role of Coenzyme Q10 as an adjuvant to nanostructured lipid carriers loaded with Adenium obesum in ethanol-induced cognitive impairment models. The work integrates molecular biology, biochemistry, and pharmacokinetic analysis to identify novel therapeutic pathways and biomarker targets. Emphasis is also placed on nanocarrier-based drug delivery for neurological and cardiovascular disorders, focusing on improving bioavailability and site-specific targeting. Parallel research on nanotherapeutics addresses challenges in treating conditions such as Alzheimer’s disease, psoriasis, and Clostridioides difficile infection. The studies utilize a combination of in silico, in vitro, and in vivo methodologies to develop innovative solutions in pharmacology and toxicology. Through experimental validation and advanced modeling, this research contributes to understanding drug mechanisms, enhancing safety profiles, and formulating next-generation therapeutics for complex diseases, thereby supporting the global goal of precision medicine and sustainable healthcare innovation.

Featured Publications

Rai, A., Shukla, S., Gupta, R. K., & Mishra, A. (2025). ALS: A silent slayer of motor neurons. Traditional Chinese herbal medicine as an effective therapy. Current Pharmaceutical Design.

Singh, V., Ravindranath, S. K., Verma, H., Shukla, S., Rai, A., Patani, T., Mishra, T., Mishra, A., & Gupta, R. K. (2025). Harnessing traditional Chinese medicine for wound healing and modern wound models: An overview. Pharmacological Research: Modern Chinese Medicine.

Pal, R., Shukla, S., Rai, A., & Sharma, A. (2025, September 25). Nano-brain revolution in Alzheimer’s disease: A new era of brain drug delivery. [Book].

Pal, R., Shukla, S., Gupta, R. K., Rai, A., & Sharma, P. (2025, September 13). From ancient roots to nano routes: Targeted delivery of Ginkgo and Gastrodia for Parkinson’s disease (PD) treatment. [Book].

Fabian Fries| Medicine and Dentistry | Young Scientist Award

Mrs. Fabian Fries| Medicine and Dentistry | Young Scientist Award

Universitätsklinikum des Saarlandes, Germany

Dr. Fabian Fries is a Senior Consultant at Saarland University Medical Center, Homburg, Germany. He specializes in ophthalmology, with extensive international experience. After completing his medical studies at Saarland University, he trained as an ophthalmology resident. Dr. Fries has also worked in various global medical centers, including in the USA, Brazil, and Germany. His research in ophthalmology has contributed to a deeper understanding of ocular diseases, particularly those associated with aniridia and keratopathy. He holds multiple certifications in medical and clinical practices.

Publication Profile

Scholar

🎓 Education

Dr. Fabian Fries completed his high school diploma (Abitur) in 2009 in Saarland, Germany. He pursued a degree in Medicine at Saarland University from 2009 to 2016, completing the State Medical Examination. Throughout his education, Dr. Fries participated in various internships and clinical rotations, including experiences at prestigious international institutions like Children’s of Alabama, USA, and Instituto de Neurologia de Curitiba, Brazil. He further honed his skills through several specialized courses and certifications.

💼 Experience

Dr. Fries’ professional journey began with medical internships in Germany. From 2016 to 2021, he worked as an ophthalmology resident at Saarland University Medical Center. He gained international exposure through internships in the USA and Brazil, before taking on the role of Senior Consultant in 2021 at the same institution. His career has focused on advancing ophthalmology care, specifically in corneal diseases and ocular surface disorders, while mentoring medical students and residents.

🏆 Awards & Honors

Dr. Fries has earned several accolades, including scholarships from Saarland University and DAAD. He also received recognition for his contributions to ophthalmology research. His work has been widely cited, and he holds an impressive H-index of 16. Dr. Fries has been awarded for his academic achievements, including participation in prestigious international conferences. His research impact is reflected in numerous publications and his status as a prominent figure in his field.

🔬 Research Focus

Dr. Fries’ research primarily addresses ocular surface disorders, with a particular focus on congenital aniridia and keratopathy. His work includes investigating the molecular mechanisms underlying corneal diseases and evaluating therapeutic options for patients with these conditions. He is dedicated to advancing the understanding of tear film dynamics, ocular surface health, and treatment efficacy in congenital diseases, contributing significantly to the field of ophthalmology.

Conclusion

Dr. Fabian Fries is a highly qualified candidate for the Young Scientist Award, with an impressive blend of clinical experience, academic rigor, and international exposure. His dedication to advancing ophthalmology through research is evident from his significant contributions to the field. While his career trajectory is already exemplary, there are opportunities for further growth by broadening the scope of his research collaborations and increasing the visibility of his work. Given his potential and the quality of his achievements, Dr. Fries is well-deserving of this prestigious recognition.

Publication Top Notes

Title: PAX6 mutational status determines aniridia-associated keratopathy phenotype
Authors: N Lagali, B Wowra, FN Fries, L Latta, K Moslemani, TP Utheim, …
Year: 2020

Title: Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations
Authors: N Lagali, B Wowra, FN Fries, L Latta, K Moslemani, TP Utheim, …
Year: 2020

Title: Abnormal neovascular and proliferative conjunctival phenotype in limbal stem cell deficiency is associated with altered microRNA and gene expression modulated by PAX6
Authors: L Latta, N Ludwig, L Krammes, T Stachon, FN Fries, A Mukwaya, …
Year: 2021

Title: Photoaging smartphone app promoting poster campaign to reduce smoking prevalence in secondary schools: the Smokerface Randomized Trial: design and baseline characteristics
Authors: TJ Brinker, J Holzapfel, TG Baudson, K Sies, L Jakob, HM Baumert, …
Year: 2016

Title: Dysfunction of the limbal epithelial stem cell niche in aniridia-associated keratopathy
Authors: U Schlötzer-Schrehardt, L Latta, A Gießl, M Zenkel, FN Fries, …
Year: 2021

Title: Expression of retinoic acid signaling components ADH7 and ALDH1A1 is reduced in aniridia limbal epithelial cells and a siRNA primary cell based aniridia model
Authors: L Latta, K Nordström, T Stachon, A Langenbucher, FN Fries, N Szentmáry, …
Year: 2019

Title: A medical student-delivered smoking prevention program, education against tobacco, for secondary schools in Germany: randomized controlled trial
Authors: TJ Brinker, AD Owczarek, W Seeger, DA Groneberg, CM Brieske, …
Year: 2017

Title: Enigmatic human tails: A review of their history, embryology, classification, and clinical manifestations
Authors: RS Tubbs, J Malefant, M Loukas, W Jerry Oakes, RJ Oskouian, FN Fries
Year: 2016